Preoperative vs. Postoperative Misoprostol in Elective Cesarean Section
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This prospective double-blind placebo-controlled randomized clinical trial will be conducted
at Ain-Shams University Maternity Hospital from April 2017 till October 2017. 120 women
candidate foe elective cesarean section will receive preoperative sublingual 400 microgram of
misoprostol, and another 120 women will receive postoperative sublingual 400 microgram of
misoprostol.